v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 12 Months Ended
Mar. 29, 2025
Mar. 30, 2024
Dec. 28, 2024
Cash flows from operating activities:      
Net loss $ (3,113,533) $ (32,548,215) $ (43,900,000)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 219,501 195,399  
Stock-based compensation 774,392 734,928  
Investment impairment net of unrealized gains 24,000  
Income taxes 52,228  
Foreign currency (gains) losses (65,901) 66,132  
Provision for credit losses  
Noncash provision for excess inventory 551,758 771,580  
Accrued litigation damages 24,800,000  
Changes in assets and liabilities:      
Accounts receivable 4,775,817 3,082,659  
Contract assets (2,273,850) (2,177,260)  
Inventory (444,726) 694,949  
Prepaid expenses, other current assets and other assets (773,832) (366,540)  
Accounts payable and accrued expenses (2,953,405) 1,682,980  
Accrued warranty (122,389) 184  
Contract liabilities and billings in excess of revenue earned (64,261) (43,746)  
Net cash used in operating activities (3,414,201) (3,106,950) (14,200,000)
Cash flows from investing activities:      
Capital expenditures (500,492) (245,429)  
Purchases of marketable securities (15,156,585) (230,012)  
Proceeds from sale of marketable securities 20,243,677 5,000,060  
Other assets (17)  
Net cash from investing activities 4,586,583 4,524,619  
Cash flows from financing activities:      
Issuance of common stock, net of costs 7,242,581  
Net cash provided by financing activities 7,242,581  
Effect of exchange rate changes on cash (588) (2,173)  
Net increase in cash, cash equivalents and restricted cash 1,171,794 8,658,077  
Cash, cash equivalents and restricted cash:      
Beginning of period 15,210,120 6,210,685 6,210,685
End of period $ 16,381,914 $ 14,868,762 $ 15,210,120